Evaluation of effectiveness of orlistat in complexed obesity treatment in teenagers with metabolic syndrome

An open, comparative, randomized study of orlistat in the combined treatment of obesity in adolescents with metabolic syndrome (IIIb phase) was held. Objective: to evaluate the efficacy and safety of the orlistat in adolescents 12-17 years with high risk of cardiovascular disease and type 2 diabetes...

Full description

Bibliographic Details
Format: Article
Language:English
Published: Endocrinology Research Centre 2011-12-01
Series:Ожирение и метаболизм
Subjects:
Online Access:https://endojournals.ru/index.php/omet/article/view/5302